WallStreetZenWallStreetZen

NASDAQ: VIGL
Vigil Neuroscience Inc Stock Forecast, Predictions & Price Target

Analyst price target for VIGL

Based on 4 analysts offering 12 month price targets for Vigil Neuroscience Inc.
Min Forecast
$4.00+27.8%
Avg Forecast
$18.50+491.05%
Max Forecast
$24.00+666.77%

Should I buy or sell VIGL stock?

Based on 4 analysts offering ratings for Vigil Neuroscience Inc.
Hold
Strong Buy
0 analysts 0%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their VIGL stock forecasts and price targets.

VIGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-19
lockedlocked$00.00+00.00%2023-11-17
lockedlocked$00.00+00.00%2023-10-18
lockedlocked$00.00+00.00%2023-09-14

1 of 1

Forecast return on equity

Is VIGL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.62%

Forecast return on assets

Is VIGL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VIGL revenue forecast

What is VIGL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$47.2M
Avg 2 year Forecast
$138.7M
Avg 3 year Forecast
$126.2M

VIGL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VIGL$3.13$18.50+491.05%Hold
LIFE$1.91$35.00+1,732.46%Buy
CYT$3.10$3.00-3.23%Sell
RNAC$0.73N/AN/A
ANIX$3.59$12.00+234.26%Buy

Vigil Neuroscience Stock Forecast FAQ

Is Vigil Neuroscience Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: VIGL) stock is to Hold VIGL stock.

Out of 4 analysts, 0 (0%) are recommending VIGL as a Strong Buy, 3 (75%) are recommending VIGL as a Buy, 0 (0%) are recommending VIGL as a Hold, 0 (0%) are recommending VIGL as a Sell, and 1 (25%) are recommending VIGL as a Strong Sell.

If you're new to stock investing, here's how to buy Vigil Neuroscience stock.

What is VIGL's revenue growth forecast for 2025-2027?

(NASDAQ: VIGL) Vigil Neuroscience's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 52.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10%.

Vigil Neuroscience's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast VIGL's revenue for 2025 to be $1,693,055,497, with the lowest VIGL revenue forecast at $1,693,055,497, and the highest VIGL revenue forecast at $1,693,055,497. On average, 1 Wall Street analysts forecast VIGL's revenue for 2026 to be $4,976,198,293, with the lowest VIGL revenue forecast at $4,976,198,293, and the highest VIGL revenue forecast at $4,976,198,293.

In 2027, VIGL is forecast to generate $4,526,295,433 in revenue, with the lowest revenue forecast at $1,881,053,183 and the highest revenue forecast at $7,171,537,684.

What is VIGL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VIGL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VIGL's Price Target?

According to 4 Wall Street analysts that have issued a 1 year VIGL price target, the average VIGL price target is $18.50, with the highest VIGL stock price forecast at $24.00 and the lowest VIGL stock price forecast at $4.00.

On average, Wall Street analysts predict that Vigil Neuroscience's share price could reach $18.50 by Dec 19, 2024. The average Vigil Neuroscience stock price prediction forecasts a potential upside of 491.05% from the current VIGL share price of $3.13.

What is VIGL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VIGL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.